Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
- 19 January 2000
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 10 (1) , 33-41
- https://doi.org/10.1046/j.1525-1438.2000.00003.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Role of Vascular Endothelial Growth Factor in Ovarian CancerThe American Journal of Pathology, 1998
- ArticleThe Lancet, 1998
- Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven PolymerizationJournal of Biological Chemistry, 1997
- The Interplay between Primary and Secondary CytokinesDrugs, 1997
- Identification of a Human Mitotic Checkpoint Gene: hsMAD2Science, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerCancer, 1994
- Growth Inhibition of Ovarian Cancer Cells Induced by Antisense IL-6 OligonucleotidesGynecologic Oncology, 1993
- Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF releaseScience, 1990